Logo image of ICAD.PA

ICADE (ICAD.PA) Stock Fundamental Analysis

Europe - EPA:ICAD - FR0000035081 - REIT

21.28 EUR
+0.12 (+0.57%)
Last: 9/18/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, ICAD scores 3 out of 10 in our fundamental rating. ICAD was compared to 40 industry peers in the Diversified REITs industry. ICAD has a bad profitability rating. Also its financial health evaluation is rather negative. ICAD is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ICAD was profitable.
ICAD had a positive operating cash flow in the past year.
In multiple years ICAD reported negative net income over the last 5 years.
ICAD had a positive operating cash flow in each of the past 5 years.
ICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

With a Return On Assets value of -1.85%, ICAD is not doing good in the industry: 82.50% of the companies in the same industry are doing better.
ICAD's Return On Equity of -4.79% is on the low side compared to the rest of the industry. ICAD is outperformed by 85.00% of its industry peers.
The Return On Invested Capital of ICAD (2.76%) is worse than 70.00% of its industry peers.
ICAD had an Average Return On Invested Capital over the past 3 years of 2.14%. This is in line with the industry average of 3.43%.
The last Return On Invested Capital (2.76%) for ICAD is above the 3 year average (2.14%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -1.85%
ROE -4.79%
ROIC 2.76%
ROA(3y)-4.37%
ROA(5y)-2.07%
ROE(3y)-10.21%
ROE(5y)-4.69%
ROIC(3y)2.14%
ROIC(5y)2.38%
ICAD.PA Yearly ROA, ROE, ROICICAD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

ICAD's Operating Margin of 19.60% is on the low side compared to the rest of the industry. ICAD is outperformed by 85.00% of its industry peers.
In the last couple of years the Operating Margin of ICAD has declined.
The Profit Margin and Gross Margin are not available for ICAD so they could not be analyzed.
Industry RankSector Rank
OM 19.6%
PM (TTM) N/A
GM N/A
OM growth 3Y-28.23%
OM growth 5Y-3.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ICAD.PA Yearly Profit, Operating, Gross MarginsICAD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ICAD is destroying value.
ICAD has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, ICAD has more shares outstanding
The debt/assets ratio for ICAD is higher compared to a year ago.
ICAD.PA Yearly Shares OutstandingICAD.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ICAD.PA Yearly Total Debt VS Total AssetsICAD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

ICAD has an Altman-Z score of 0.64. This is a bad value and indicates that ICAD is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.64, ICAD is doing worse than 65.00% of the companies in the same industry.
The Debt to FCF ratio of ICAD is 45.49, which is on the high side as it means it would take ICAD, 45.49 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ICAD (45.49) is worse than 82.50% of its industry peers.
A Debt/Equity ratio of 0.97 indicates that ICAD is somewhat dependend on debt financing.
ICAD's Debt to Equity ratio of 0.97 is on the low side compared to the rest of the industry. ICAD is outperformed by 77.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 45.49
Altman-Z 0.64
ROIC/WACC0.99
WACC2.8%
ICAD.PA Yearly LT Debt VS Equity VS FCFICAD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 1.06 indicates that ICAD should not have too much problems paying its short term obligations.
ICAD's Current ratio of 1.06 is fine compared to the rest of the industry. ICAD outperforms 72.50% of its industry peers.
A Quick Ratio of 0.81 indicates that ICAD may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.81, ICAD is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.81
ICAD.PA Yearly Current Assets VS Current LiabilitesICAD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1

3. Growth

3.1 Past

The earnings per share for ICAD have decreased strongly by -72.25% in the last year.
ICAD shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.69% yearly.
Looking at the last year, ICAD shows a very negative growth in Revenue. The Revenue has decreased by -13.82% in the last year.
Measured over the past years, ICAD shows a small growth in Revenue. The Revenue has been growing by 0.64% on average per year.
EPS 1Y (TTM)-72.25%
EPS 3YN/A
EPS 5Y-9.69%
EPS Q2Q%-10.91%
Revenue 1Y (TTM)-13.82%
Revenue growth 3Y-1.82%
Revenue growth 5Y0.64%
Sales Q2Q%-74.49%

3.2 Future

Based on estimates for the next years, ICAD will show a decrease in Earnings Per Share. The EPS will decrease by -1.45% on average per year.
ICAD is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.36% yearly.
EPS Next Y10.58%
EPS Next 2Y2.48%
EPS Next 3Y-1.45%
EPS Next 5YN/A
Revenue Next Year-6.62%
Revenue Next 2Y-1.93%
Revenue Next 3Y-1.36%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ICAD.PA Yearly Revenue VS EstimatesICAD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
ICAD.PA Yearly EPS VS EstimatesICAD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 7.14 indicates a rather cheap valuation of ICAD.
Based on the Price/Earnings ratio, ICAD is valued cheaper than 95.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.41, ICAD is valued rather cheaply.
A Price/Forward Earnings ratio of 6.41 indicates a rather cheap valuation of ICAD.
ICAD's Price/Forward Earnings ratio is rather cheap when compared to the industry. ICAD is cheaper than 97.50% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.88. ICAD is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.14
Fwd PE 6.41
ICAD.PA Price Earnings VS Forward Price EarningsICAD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

92.50% of the companies in the same industry are more expensive than ICAD, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ICAD is valued a bit more expensive than 60.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.78
EV/EBITDA 10.54
ICAD.PA Per share dataICAD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

ICAD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.68
PEG (5Y)N/A
EPS Next 2Y2.48%
EPS Next 3Y-1.45%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.56%, ICAD is a good candidate for dividend investing.
ICAD's Dividend Yield is comparable with the industry average which is at 5.57.
ICAD's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 5.56%

5.2 History

The dividend of ICAD has a limited annual growth rate of 1.04%.
Dividend Growth(5Y)1.04%
Div Incr Years1
Div Non Decr Years1
ICAD.PA Yearly Dividends per shareICAD.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

The earnings of ICAD are negative and hence is the payout ratio. ICAD will probably not be able to sustain this dividend level.
DP-185.46%
EPS Next 2Y2.48%
EPS Next 3Y-1.45%
ICAD.PA Yearly Income VS Free CF VS DividendICAD.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B

ICADE

EPA:ICAD (9/18/2025, 7:00:00 PM)

21.28

+0.12 (+0.57%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)07-23 2025-07-23/amc
Earnings (Next)10-20 2025-10-20
Inst Owners72.7%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap1.62B
Analysts69.47
Price Target24.85 (16.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.56%
Yearly Dividend4.84
Dividend Growth(5Y)1.04%
DP-185.46%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.35%
PT rev (3m)-3.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)3.21%
EPS NY rev (3m)3.21%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.55%
Revenue NY rev (3m)2.31%
Valuation
Industry RankSector Rank
PE 7.14
Fwd PE 6.41
P/S 1.08
P/FCF 15.78
P/OCF 4.94
P/B 0.42
P/tB 0.42
EV/EBITDA 10.54
EPS(TTM)2.98
EY14%
EPS(NY)3.32
Fwd EY15.6%
FCF(TTM)1.35
FCFY6.34%
OCF(TTM)4.31
OCFY20.24%
SpS19.67
BVpS51.19
TBVpS50.76
PEG (NY)0.68
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.85%
ROE -4.79%
ROCE 3.87%
ROIC 2.76%
ROICexc 3.38%
ROICexgc 3.4%
OM 19.6%
PM (TTM) N/A
GM N/A
FCFM 6.86%
ROA(3y)-4.37%
ROA(5y)-2.07%
ROE(3y)-10.21%
ROE(5y)-4.69%
ROIC(3y)2.14%
ROIC(5y)2.38%
ROICexc(3y)2.49%
ROICexc(5y)2.67%
ROICexgc(3y)2.5%
ROICexgc(5y)2.68%
ROCE(3y)3.06%
ROCE(5y)3.38%
ROICexcg growth 3Y-8.78%
ROICexcg growth 5Y2.92%
ROICexc growth 3Y-8.79%
ROICexc growth 5Y2.96%
OM growth 3Y-28.23%
OM growth 5Y-3.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 45.49
Debt/EBITDA 9.41
Cap/Depr 211.04%
Cap/Sales 15.05%
Interest Coverage 4.1
Cash Conversion 81.96%
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.81
Altman-Z 0.64
F-Score5
WACC2.8%
ROIC/WACC0.99
Cap/Depr(3y)678.24%
Cap/Depr(5y)1255.8%
Cap/Sales(3y)20.42%
Cap/Sales(5y)31.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.25%
EPS 3YN/A
EPS 5Y-9.69%
EPS Q2Q%-10.91%
EPS Next Y10.58%
EPS Next 2Y2.48%
EPS Next 3Y-1.45%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.82%
Revenue growth 3Y-1.82%
Revenue growth 5Y0.64%
Sales Q2Q%-74.49%
Revenue Next Year-6.62%
Revenue Next 2Y-1.93%
Revenue Next 3Y-1.36%
Revenue Next 5YN/A
EBIT growth 1Y74.88%
EBIT growth 3Y-29.53%
EBIT growth 5Y-3.23%
EBIT Next Year45.89%
EBIT Next 3Y14.53%
EBIT Next 5Y8.67%
FCF growth 1Y240.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.57%
OCF growth 3Y-11.53%
OCF growth 5Y-0.14%